Novo, Hims & Hers Make Up, Agree To Sell GLP-1s Together

By Theresa Schliep · March 9, 2026, 6:52 PM EDT

Novo Nordisk A/S will start selling its GLP-1 medications on Hims & Hers Health Inc.'s platform as part of a deal that resolves the pharmaceutical company's patent infringement lawsuit against the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Notice

Case Information

Case Title

Novo Nordisk A/S et al v. Hims & Hers Health, Inc. et al

Case Number

Court

Delaware

Nature of Suit

Patent

Date Filed

February 09, 2026

Recent Articles By Theresa

February 20, 2026
Fed. Circ. Unwinds Ineligibility Ruling For Gene Therapy IP
February 04, 2026
Squires Throws Out 23 Patent Challenges, Grants 12
January 26, 2026
Masimo Chafes Against Apple's Bid To Duck $634M IP Verdict
January 20, 2026
Fed. Circ. Revives Inventor's Spinal Patent Case Against DePuy
December 02, 2025
Defamation Litigation Roundup: FDA, Lively, Alexander Bros.
November 26, 2025
USPTO, DOJ Tell ITC To Limit Exceptions In Netlist Case
November 20, 2025
Where Apple And Masimo's Watch Patent Fight Stands Now
November 14, 2025
ITC To Scrutinize Redesigned Apple Watch In Masimo IP Fight
October 28, 2025
Apple Spared From Some Masimo Patent Claims Before Trial
October 17, 2025
Mixed Discretionary Denial Batch Caps Off Big Week For PTAB